Article info
Editorial
Biosimilars to treat inflammatory arthritis: the challenge of proving identity
- Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Memorial Campus, 119 Belmont Street, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org.
Citation
Biosimilars to treat inflammatory arthritis: the challenge of proving identity
Publication history
- Received May 13, 2013
- Revised July 6, 2013
- Accepted July 9, 2013
- First published July 29, 2013.
Online issue publication
September 04, 2013
Article Versions
- Previous version (29 July 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions